The Cooper Companies, Inc. (NYSE:COO) Shares Sold by Barclays PLC

Posted by on Aug 6th, 2023

Barclays PLC reduced its stake in The Cooper Companies, Inc. (NYSE:COO – Free Report) by 10.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 71,685 shares of the medical device company’s stock after selling 7,936 shares during the period. Barclays PLC owned 0.14% of Cooper Companies worth $26,763,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Raymond James Financial Services Advisors Inc. lifted its position in shares of Cooper Companies by 41.1% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 1,666 shares of the medical device company’s stock valued at $696,000 after acquiring an additional 485 shares in the last quarter. American Century Companies Inc. grew its holdings in shares of Cooper Companies by 9.6% during the first quarter. American Century Companies Inc. now owns 2,494 shares of the medical device company’s stock valued at $1,041,000 after buying an additional 219 shares in the last quarter. Private Advisor Group LLC raised its position in Cooper Companies by 16.5% during the first quarter. Private Advisor Group LLC now owns 1,005 shares of the medical device company’s stock valued at $419,000 after buying an additional 142 shares during the period. Dimensional Fund Advisors LP lifted its stake in Cooper Companies by 1.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 247,446 shares of the medical device company’s stock worth $103,341,000 after acquiring an additional 2,527 shares in the last quarter. Finally, Aviva PLC boosted its position in Cooper Companies by 18.6% during the 1st quarter. Aviva PLC now owns 19,589 shares of the medical device company’s stock worth $8,180,000 after acquiring an additional 3,070 shares during the period. 98.36% of the stock is currently owned by institutional investors.

Cooper Companies Stock Down 0.3 %

COO opened at $388.79 on Friday. The Cooper Companies, Inc. has a twelve month low of $244.21 and a twelve month high of $399.62. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.95 and a current ratio of 1.69. The business has a 50 day moving average price of $376.73 and a 200 day moving average price of $365.51. The firm has a market cap of $19.25 billion, a P/E ratio of 67.03, a price-to-earnings-growth ratio of 3.05 and a beta of 0.90.

Cooper Companies (NYSE:COO – Get Free Report) last issued its quarterly earnings results on Thursday, June 1st. The medical device company reported $3.08 EPS for the quarter, topping analysts’ consensus estimates of $3.04 by $0.04. The company had revenue of $877.40 million during the quarter, compared to analyst estimates of $865.81 million. Cooper Companies had a return on equity of 8.18% and a net margin of 8.41%. The company’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the previous year, the company earned $3.24 earnings per share. Research analysts forecast that The Cooper Companies, Inc. will post 12.79 EPS for the current year.

Cooper Companies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 11th. Investors of record on Thursday, July 27th will be paid a $0.03 dividend. The ex-dividend date is Wednesday, July 26th. This represents a $0.12 dividend on an annualized basis and a yield of 0.03%. Cooper Companies’s payout ratio is currently 1.03%.

Analyst Ratings Changes

A number of brokerages have recently weighed in on COO. Robert W. Baird upped their target price on Cooper Companies from $385.00 to $400.00 in a report on Friday, June 2nd. Stifel Nicolaus lifted their target price on shares of Cooper Companies from $380.00 to $420.00 in a research note on Tuesday, May 16th. StockNews.com began coverage on shares of Cooper Companies in a research note on Thursday, May 18th. They issued a “hold” rating on the stock. Citigroup lifted their price objective on Cooper Companies from $431.00 to $440.00 in a research report on Monday, July 10th. Finally, Wells Fargo & Company boosted their target price on Cooper Companies from $355.00 to $430.00 in a research note on Monday, May 15th. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, Cooper Companies has an average rating of “Moderate Buy” and a consensus target price of $399.44.

Cooper Companies Profile

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Featured Stories

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NYSE:COO – Free Report).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.